Cargando…

Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia

BACKGROUND: The Australian National Antimicrobial Resistance Strategy calls for a collaborative effort to change practices that have contributed to the development of drug-resistance and for implementation of new initiatives to reduce antibiotic use. METHODS: A facilitated workshop was undertaken at...

Descripción completa

Detalles Bibliográficos
Autores principales: Merlo, Gregory, Avent, Minyon, Yarwood, Trent, Smith, Bonnie, van Driel, Mieke, Hall, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164738/
https://www.ncbi.nlm.nih.gov/pubmed/34051866
http://dx.doi.org/10.1186/s13756-021-00953-4
_version_ 1783701179425882112
author Merlo, Gregory
Avent, Minyon
Yarwood, Trent
Smith, Bonnie
van Driel, Mieke
Hall, Lisa
author_facet Merlo, Gregory
Avent, Minyon
Yarwood, Trent
Smith, Bonnie
van Driel, Mieke
Hall, Lisa
author_sort Merlo, Gregory
collection PubMed
description BACKGROUND: The Australian National Antimicrobial Resistance Strategy calls for a collaborative effort to change practices that have contributed to the development of drug-resistance and for implementation of new initiatives to reduce antibiotic use. METHODS: A facilitated workshop was undertaken at the 2019 National Australian Antimicrobial Resistance Forum to explore the complexity of antimicrobial stewardship (AMS) implementation in Australia and prioritise future action. Participants engaged in rotating rounds of discussion using a world café format addressing six topics relating to AMS implementation. Once all tables had discussed all themes the discussion concluded and notes were summarised. The documents were independently openly coded by two researchers to identify elements relating to the implementation of antimicrobial stewardship. RESULTS: There were 39 participants in the facilitated discussions, including pharmacists, infectious disease physicians, infection prevention nurses, and others. Participants discussed strategies they had found successful, including having a regular presence in clinical areas, adapting messaging and implementation strategies for different disciplines, maintaining positivity, and being patient-focused. Many of the recommendations for the next step involved being patient focussed and outcomesdriven. This involves linking data to practice, using patient stories, using data to celebrate wins and creating incentives. DISCUSSION: Recommendations from the workshop should be included in priority setting for the implementation of AMS initiatives across Australia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-021-00953-4.
format Online
Article
Text
id pubmed-8164738
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81647382021-06-01 Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia Merlo, Gregory Avent, Minyon Yarwood, Trent Smith, Bonnie van Driel, Mieke Hall, Lisa Antimicrob Resist Infect Control Letter to the Editor BACKGROUND: The Australian National Antimicrobial Resistance Strategy calls for a collaborative effort to change practices that have contributed to the development of drug-resistance and for implementation of new initiatives to reduce antibiotic use. METHODS: A facilitated workshop was undertaken at the 2019 National Australian Antimicrobial Resistance Forum to explore the complexity of antimicrobial stewardship (AMS) implementation in Australia and prioritise future action. Participants engaged in rotating rounds of discussion using a world café format addressing six topics relating to AMS implementation. Once all tables had discussed all themes the discussion concluded and notes were summarised. The documents were independently openly coded by two researchers to identify elements relating to the implementation of antimicrobial stewardship. RESULTS: There were 39 participants in the facilitated discussions, including pharmacists, infectious disease physicians, infection prevention nurses, and others. Participants discussed strategies they had found successful, including having a regular presence in clinical areas, adapting messaging and implementation strategies for different disciplines, maintaining positivity, and being patient-focused. Many of the recommendations for the next step involved being patient focussed and outcomesdriven. This involves linking data to practice, using patient stories, using data to celebrate wins and creating incentives. DISCUSSION: Recommendations from the workshop should be included in priority setting for the implementation of AMS initiatives across Australia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-021-00953-4. BioMed Central 2021-05-29 /pmc/articles/PMC8164738/ /pubmed/34051866 http://dx.doi.org/10.1186/s13756-021-00953-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Merlo, Gregory
Avent, Minyon
Yarwood, Trent
Smith, Bonnie
van Driel, Mieke
Hall, Lisa
Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia
title Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia
title_full Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia
title_fullStr Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia
title_full_unstemmed Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia
title_short Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia
title_sort where to from here? identifying and prioritising future directions for addressing drug-resistant infection in australia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164738/
https://www.ncbi.nlm.nih.gov/pubmed/34051866
http://dx.doi.org/10.1186/s13756-021-00953-4
work_keys_str_mv AT merlogregory wheretofromhereidentifyingandprioritisingfuturedirectionsforaddressingdrugresistantinfectioninaustralia
AT aventminyon wheretofromhereidentifyingandprioritisingfuturedirectionsforaddressingdrugresistantinfectioninaustralia
AT yarwoodtrent wheretofromhereidentifyingandprioritisingfuturedirectionsforaddressingdrugresistantinfectioninaustralia
AT smithbonnie wheretofromhereidentifyingandprioritisingfuturedirectionsforaddressingdrugresistantinfectioninaustralia
AT vandrielmieke wheretofromhereidentifyingandprioritisingfuturedirectionsforaddressingdrugresistantinfectioninaustralia
AT halllisa wheretofromhereidentifyingandprioritisingfuturedirectionsforaddressingdrugresistantinfectioninaustralia